What we’re building

At Kind we're building the integrated organ network, or ION platform. It uses artificial genomic constructs to grow a set of peripheral organs that depend on each other for normal development and function.

This interdependent approach is designed to support ethical and scalable production of xenotransplant organs.

Why this matters

Transplant medicine is severely supply constrained. The ION platform enables scalable production of high quality organs.

This will remove organ shortage as the limiting factor and make replacement a practical tool for treating age related organ decline and failure.

For example, most patients with ischemic cardiomyopathy due to advanced coronary artery disease rarely receive transplants today due to scarcity.

With abundant high-quality organs available, replacing failing ones could let people live longer, healthier lives - giving them more time to enjoy family, watch their kids or grandkids grow up, and make the most of the years that matter most.

Longer term

In the longer term, replacing multiple interconnected organs will unlock profound systemic rejuvenation. Far beyond their isolated functions, these vital organs actively shape the entire physiological environment of the body. Ultimately, the strategic replacement of failing biological parts represents the most direct and transformative pathway to extending healthy human lifespan.